Download Full eBooks in PDF
Pharmacy Benefit Managers Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Pharmacy Benefit Managers book. This book definitely worth reading, it is an incredibly well-written.
Author : Anonim
Publisher : Unknown
Page : 38 pages
File Size : 43,9 Mb
Release : 1995
Category : Managed care plans (Medical care)
ISBN : CORNELL:31924074091996
Author : United States. General Accounting Office
Publisher : Unknown
Page : 28 pages
File Size : 51,9 Mb
Release : 1997
Category : Drugs
ISBN : UOM:39015048857109
Author : Sheila Shulman,Elaine M Healy
Publisher : CRC Press
Page : 216 pages
File Size : 44,8 Mb
Release : 1998-06-18
Category : Medical
ISBN : 0789005123
PBMs: Reshaping the Pharmaceutical Distribution Network provides HMOs and other third-party payers with information on the new and increasingly important role of pharmaceutical benefit companies (PBMs) in the health care industry. From this text, you will learn how PBMs can maintain and deliver a quality, cost-effective drug benefit plan to your company while achieving the anticipated market share for the product. PBMs: Reshaping the Pharmaceutical Distribution Network offers you suggestions on how to choose which PBM service is correct for your business, such as what qualifications to look for in a PBM, as well as what questions you should ask a respective company. This text also offers ways on how your company can benefit from becoming a client and may make your business more competitive in the pharmaceutical industry. PBMs: Reshaping the Pharmaceutical Distribution Network also informs you about the controversies that have arisen concerning the new position of PBMs in the industry. Through research and evaluation, this text addresses these issues from many different perspectives and gives you insight into other topics concerning PBMs, including: operating methods that PBMs currently rely on for designing and overseeing a drug benefit plan how the Food and Drug Administration currently views the role of PBMs and why they are contemplating regulatory intervention alerting PBMs, pharmacies, pharmaceutical companies, and managed care organizations to new legal issues involving fraud and abuse affecting pharmacy benefit management and pharmaceutical manufacturers reasons why retail drug chains and pharmacist organizations oppose recent industry developments regarding PBMs whether or not PBMs reflect a move toward greater centralized decisionmaking in the health care systemIn addition, PBMs: Reshaping the Pharmaceutical Distribution Network offers pharmaceutical companies, health care providers, and managed care organizations several suggestions for further research, which may make your business or your business relationships more efficient and productive in the future. If you or your company are considering the services of a pharmacy benefit management, PBMs: Reshaping the Pharmaceutical Distribution Network will guide you in choosing a company that helps you deliver the most cost-effective and efficient pharmaceutical benefits to customers.
Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Publisher : National Academies Press
Page : 235 pages
File Size : 43,6 Mb
Release : 2018-03-01
Category : Medical
ISBN : 9780309468084
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author : DIANE Publishing Company
Publisher : DIANE Publishing
Page : 30 pages
File Size : 45,7 Mb
Release : 1996-07
Category : Electronic
ISBN : 0788132091
Studies the mergers & alliances of pharmaceutical manufacturers with pharmacy benefit managers (PBM) -- companies that manage prescription drug benefits for health plans. This study determines the role of the PBMs in the health care industry; the objectives of these ventures; specific concerns about the effect of these ventures on competition in markets served by drug manufacturers and PBMs; & the extent to which the PBMs have given preference to their manufacturer partners' drugs. Charts & tables.
Author : United States. General Accounting Office
Publisher : Unknown
Page : 48 pages
File Size : 52,6 Mb
Release : 2003
Category : Government employees' health insurance
ISBN : CORNELL:31924091740047
Author : United States. Department of Health and Human Services. Office of Inspector General
Publisher : Unknown
Page : 166 pages
File Size : 42,5 Mb
Release : 1997
Category : Health maintenance organizations
ISBN : HARVARD:32044070767900
Author : F. Randy Vogenberg
Publisher : International Foundation of Employee benefit
Page : 180 pages
File Size : 47,5 Mb
Release : 2011
Category : Business & Economics
ISBN : 0891546960
Pharmaceuticals have become an integral component of medical treatment, with some medications completely transforming health care outcomes and delivery. Drug therapy has been proven to reduce health care costs, increase productivity and enhance the quality of life for many people. When was the last time you examined the prescription drug component of your health care benefits? This primer offers factors to consider when designing or modifying pharmacy benefits, including the pros and cons of carving benefits into a health plan as well as carving them out as a separate prescription drug plan. A practical checklist is provided in almost every chapter to help you focus on important issues, including what questions to ask potential vendors.
Author : United States Accounting Office (GAO)
Publisher : Createspace Independent Publishing Platform
Page : 28 pages
File Size : 40,8 Mb
Release : 2018-06-14
Category : Electronic
ISBN : 1721111522
Pharmacy Benefit Managers: Early Results on Ventures With Drug Manufacturers
Author : United States Government Accountability Office
Publisher : Createspace Independent Publishing Platform
Page : 44 pages
File Size : 43,8 Mb
Release : 2017-10-19
Category : Electronic
ISBN : 1978420471
Federal Employees' Health Benefits: Effects of Using Pharmacy Benefit Managers on Health Plans, Enrollees, and Pharmacies
Author : Thao Doan,Cheryl Renz,Fabio Lievano,Mondira Bhattacharya,Linda Scarazzini
Publisher : Elsevier Health Sciences
Page : 228 pages
File Size : 54,7 Mb
Release : 2018-07-31
Category : Medical
ISBN : 9780323581172
Written by experts in the field of pharmacovigilance and patient safety, this concise resource provides a succinct, easy-to-digest overview of an increasingly critical area of medical safety. Drs. Thao Doan, Fabio Lievano, Mondira Bhattacharya, and Linda Scarazzini provide essential information for health care professionals, clinical researchers, and regulators who need a comprehensive, up-to-date source of information on the principles and practice of pharmacovigilance.
Author : F. Vogenberg
Publisher : Unknown
Page : 117 pages
File Size : 51,9 Mb
Release : 2018-10-28
Category : Electronic
ISBN : 1729000886
A reference for all healthcare-related professionals that better helps them understand the complex world of managed pharmacy benefits, this detailed resource explains the evolution of prescription drug benefit management based on (1) enhancing access to pharmacy services, (2) containing the costs of prescription medications, (3) managing utilization of prescription drugs, and (4) managing disease states and patient outcomes. Readers will understand the relationships among pharmaceutical contracting and prescribing, pharmacy distribution and dispensing, pharmacy utilization management and policies, patient cost sharing and adherence, and how to "follow the money" throughout the system.
Author : Institute of Medicine,Division of Health Care Services,VA Pharmacy Formulary Analysis Committee
Publisher : National Academies Press
Page : 280 pages
File Size : 50,8 Mb
Release : 2000-10-03
Category : Medical
ISBN : 9780309183536
The VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated.
Author : Stan Finkelstein,Peter Temin
Publisher : FT Press
Page : 207 pages
File Size : 49,7 Mb
Release : 2008-01-23
Category : Business & Economics
ISBN : 9780132703994
A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.” –Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University “This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.” –Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration “This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.” –Honorable Barney Frank, Congressman from Massachusetts “This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.” –Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177
Author : Norrie Thomas,Lon N. Larson,Nancy N. Bell
Publisher : International Foundation of Employee benefit
Page : 144 pages
File Size : 41,9 Mb
Release : 1996
Category : Medical
ISBN : 0891544941